N-of-One Selected by OncoDNA to Provide Clinical Interpreta?tion for Next-Gener?ation Sequencing Tests Worldwide
N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, has announced an agreement with OncoDNA, the first company in Europe to provide personalized medicine in oncology based on the molecular analysis of each patient’s tumour. Under this agreement, N-of-One will provide the clinical interpretation for all of OncoDNA’s next-generation sequencing (NGS) and other molecular tests done for patients throughout Europe, the Middle East, and in other parts of the world. Fhttp://www.oncodna.cominancial terms of the agreement are not disclosed.
OncoDNA provides comprehensive tumour profiling services to assist medical doctors in their treatment choices and provide better monitoring of the evolution of patient tumours. The lab is led by a team of highly experienced experts in DNA sequencing and diagnostic analyses in oncology.
N-of-One’s clinical interpretation provides the relevant biological and clinical knowledge and insights related to the mutation profile of a tumour identified by sequencing linking this knowledge to relevant therapeutic strategies, including clinical trials.
“We selected N-of-One for their best-in-class clinical interpretation and their ability to integrate multiple types of molecular test results into a single clinical report with very fast turnaround times,” said Jean-Pol Detiffe, CEO of OncoDNA. “N-of-One’s clinical interpretation uniquely provides the clinician with actionable insights and knowledge that can be used at the point of care.”
“OncoDNA’s industry-leading, molecular diagnostic solutions, coupled with N-of-One’s deep expertise in clinical interpretation in oncology, will enable broader patient access worldwide to personalized cancer treatment in a scalable, cost-effective manner,” said Chris Cournoyer, CEO of N-of-One.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance